Publikationen von Udo Reichl

Göbel, S.; Mayerlen, L.; Eiser, I. Y.; Fichtmüller, L.; Clements, D.; Reichl, U.; Genzel, Y.; Lehrer, A. T.: Process Intensification for Recombinant Marburg Virus Glycoprotein Production UsingDrosophilaS2 Cells. Engineering in Life Sciences 25 (5), e70022 (2025)

Wolf, M.; Lange, J.; Benndorf, D.; Welz, L.; Nikolaus, S.; Siever, L. K.; Tran, F.; Schallert, K.; Hellwig, P.; Schreiber, S. et al.; Gunzer, M.; Rosenstiel, P.; Reichl, U.; Adolph, T.; Jukic, A.; Aden, K.; Heyer, R.: Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease. Journal of Proteomics 318, 105455 (2025)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Genzel, Y.; Reichl, U.: Influenza A Virus Production Following Quality by Design Principles. Engineering in Life Sciences 25 (4), e70027 (2025)

Zinnecker, T. M.; Wicke, E.; Reichl, U.; Göbel, S.; Genzel, Y.: Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production. Processes 13 (5), 1286 (2025)

Zuniga-Banuelos, F. J.; Hoffmann, M.; Reichl, U.; Rapp, E.: New Avenues for Human Blood Plasma Biomarker Discovery via Improved In-Depth Analysis of the Low-Abundant N-glycoproteome. Engineering (2025)

Göbel, S.; Kazemi, O.; Ma, J.; Jordan, I.; Sandig, V.; Paulissen, J.; Kerstens, W.; Thibaut, H. J.; Reichl, U.; Dallmeier, K. et al.; Genzel, Y.: Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 12 (7), 755 (2024)

Göbel, S.; Pelz, L.; Silva, C. A. T.; Brühlmann, B.; Hill, C.; Altomonte, J.; Kamen, A.; Reichl, U.; Genzel, Y.: Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology 108 (1), 240 (2024)

Hellwig, P.; Dittrich, A.; Heyer, R.; Reichl, U.; Benndorf, D.: Detection, isolation and characterization of phage-host complexes using BONCAT and click chemistry. Frontiers in Microbiology 15, 1434301 (2024)

Hellwig, P.; Kautzner, D.; Heyer, R.; Dittrich, A.; Wibberg, D.; Busche, T.; Winkler, A.; Reichl, U.; Benndorf, D.: Tracing active members in microbial communities by BONCAT and click chemistry-based enrichment of newly synthesized proteins. ISME Communications 4 (1), ycae153 (2024)

Heyer, R.; Hellwig, P.; Maus, I.; Walke, D.; Schlüter, A.; Hassa, J.; Sczyrba, A.; Tubbesing, T.; Klocke, M.; Mächtig, T. et al.; Schallert, K.; Seick, I.; Reichl, U.; Benndorf, D.: Breakdown of hardly degradable carbohydrates (lignocellulose) in a two-stage anaerobic digestion plant is favored in the main fermenter. Water Research 250, 121020 (2024)

Huber, N.; Alcalá Orozco, E. A.; Rexer, T.; Reichl, U.; Klamt, S.: Model-based optimization of cell-free enzyme cascades exemplified for the production of GDP-fucose. Metabolic Engineering 81, S. 10 - 25 (2024)

Karsten, C. B.; Buettner, F. F. R.; Cajic, S.; Nehlmeier, I.; Roshani, B.; Klippert, A.; Sauermann, U.; Stolte-Leeb, N.; Reichl, U.; Gerardy-Schahn, R. et al.; Rapp, E.; Stahl-Hennig, C.; Pöhlmann, S.: Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. PLOS Pathogens 20 (5), e1012190 (2024)

Khesali Aghtaei, H.; Heyer, R.; Reichl, U.; Benndorf, D.: Improved biological methanation using tubular foam-bed reactor. Biotechnology for Biofuels and Bioproducts 17, 66 (2024)

Pelz, L.; Dogra, T.; Marichal-Gallardo, P.; Hein, M. D.; Hemissi, G.; Kupke, S. Y.; Genzel, Y.; Reichl, U.: Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology 108, 97 (2024)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Pontes, C.; Laske, T.; Kupke, S. Y.; Reichl, U.: Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 27 (4), 109421 (2024)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Thiele, K.; Reichl, U.; Genzel, Y.: From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 24 (4), 2300245 (2024)

Zinnecker, T. M.; Reichl, U.; Genzel, Y.: Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations. Human Vaccines & Immunotherapeutics 20 (1), 2373521 (2024)

Alcalá Orozco, E. A.; Grote, V.; Fiebig, T.; Klamt, S.; Reichl, U.; Rexer, T.: A Cell‐Free Multi‐enzyme Cascade Reaction for the Synthesis of CDP‐Glycerol. ChemBioChem: A European Journal of Chemical Biology 24 (21), e202300463 (2023)

Burock, R.; Cajic, S.; Hennig, R.; Buettner, F. F. R.; Reichl, U.; Rapp, E.: Reliable N-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation. Molecules 28 (4), 1843 (2023)

Cajic, S.; Hennig, R.; Grote, V.; Reichl, U.; Rapp, E.: Removable Dyes—The Missing Link for In-Depth N-glycan Analysis via Multi-Method Approaches. Engineering 26, S. 132 - 150 (2023)